Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12002703rdf:typepubmed:Citationlld:pubmed
pubmed-article:12002703lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:12002703lifeskim:mentionsumls-concept:C0677944lld:lifeskim
pubmed-article:12002703lifeskim:mentionsumls-concept:C0205262lld:lifeskim
pubmed-article:12002703pubmed:issue3lld:pubmed
pubmed-article:12002703pubmed:dateCreated2002-5-10lld:pubmed
pubmed-article:12002703pubmed:abstractTextThe purpose of this study was to analyse the occurrence of non-visualisation during preoperative lymphoscintigraphy for sentinel node identification in breast cancer. Preoperative lymphoscintigraphy was performed in 495 clinically node-negative breast cancer patients (501 sentinel node procedures) after injection of technetium-99m nanocolloid. Anterior and prone lateral (hanging breast) planar images were obtained a few minutes and 4 h after injection. The sentinel node was intraoperatively identified with the aid of patent blue dye and a gamma-ray detection probe. A sentinel node was visualised on the 4-h images in 449 of 501 procedures (90%). This visualisation rate improved from 76% to 94% during the study period. Delayed imaging (5-23 h) in 19 patients whose sentinel nodes failed to show, resulted in visualisation in four of them. A repeat injection of radiocolloid in 11 patients revealed a sentinel node in six. In the end, the visualisation rate was 92%. The sentinel node was surgically retrieved in 24 of the remaining 42 patients with non-visualisation (57%). Sentinel nodes that were visualised were tumour-positive in 38% and non-visualised sentinel nodes were involved in 50% (chi2, P=0.17). In a multivariate regression analysis, scintigraphic non-visualisation was independently associated with increased patient age (P<0.001), decreased tracer dose (P<0.001) and increased number of tumour-positive lymph nodes (P=0.013). The use of a sufficient amount of radioactivity (at least 100 MBq) is recommended for lymphatic mapping in breast cancer, especially in elderly women. Delayed imaging and re-injection of the radioactive tracer increase the visualisation rate. The non-visualised sentinel node can be identified intraoperatively in more than half of the patients.lld:pubmed
pubmed-article:12002703pubmed:languageenglld:pubmed
pubmed-article:12002703pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12002703pubmed:citationSubsetIMlld:pubmed
pubmed-article:12002703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12002703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12002703pubmed:statusMEDLINElld:pubmed
pubmed-article:12002703pubmed:monthMarlld:pubmed
pubmed-article:12002703pubmed:issn1619-7070lld:pubmed
pubmed-article:12002703pubmed:authorpubmed-author:HoefnagelC...lld:pubmed
pubmed-article:12002703pubmed:authorpubmed-author:Valdés...lld:pubmed
pubmed-article:12002703pubmed:authorpubmed-author:NiewegO EOElld:pubmed
pubmed-article:12002703pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:12002703pubmed:authorpubmed-author:TanisP JPJlld:pubmed
pubmed-article:12002703pubmed:authorpubmed-author:KroonB B RBBlld:pubmed
pubmed-article:12002703pubmed:authorpubmed-author:RutgersE J...lld:pubmed
pubmed-article:12002703pubmed:issnTypePrintlld:pubmed
pubmed-article:12002703pubmed:volume29lld:pubmed
pubmed-article:12002703pubmed:ownerNLMlld:pubmed
pubmed-article:12002703pubmed:authorsCompleteYlld:pubmed
pubmed-article:12002703pubmed:pagination305-11lld:pubmed
pubmed-article:12002703pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:meshHeadingpubmed-meshheading:12002703...lld:pubmed
pubmed-article:12002703pubmed:year2002lld:pubmed
pubmed-article:12002703pubmed:articleTitleThe hidden sentinel node in breast cancer.lld:pubmed
pubmed-article:12002703pubmed:affiliationDepartment of Surgery, The Netherlands Cancer Institute, Amsterdam. ptanis@nki.nllld:pubmed
pubmed-article:12002703pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12002703pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12002703pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12002703lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12002703lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12002703lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12002703lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12002703lld:pubmed